Silo Pharma(SILO) Stock Price Today | Quotes & News

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Relmada Therapeutics RLMD Phase 2 Data; Silo Pharma SILO Patent
BioPharmCatalystApr 28 16:00 ET
Silo Pharma Files Patent Application With USPTO For SPC-14, Intranasal Compound Exclusively Licensed AD Drug
BenzingaApr 28 07:52 ET
Express News | Silo Pharma Expands Intellectual Property Portfolio With Patent Application for Exclusively Licensed Alzheimer’s Drug
ReutersApr 28 07:50 ET
Silo Pharma Offering Up to 4.7M Shrs, Together With Series A-1 and Series A-2 Warrants
Dow JonesApr 25 17:20 ET
Silo Pharma | 10-K: FY2024 Annual Report
SECMar 28 16:29 ET · Announcements
12 Health Care Stocks Moving In Wednesday's After-Market Session
BenzingaMar 26 17:05 ET

Comments

Jaguar8

Apr 28 19:50

NEWS

$Silo Pharma (SILO.US)$
Silo Pharma Expands Intellectual Property Portfolio with Patent Application for Exclusively Licensed Alzheimer's Drug
Monday, 28th April at 7:50 am
SARASOTA, FL, April 28, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (NASDAQ: SILO) ("Silo" or the "Company"), a developmental stage biopharmaceutical company focused on novel therapeutics and drug delivery systems, today announced the filing of a patent application with the U.S. Patent and Trademark Office (USPTO) focused on...

1

tomb414

Mar 26 21:06

$Silo Pharma (SILO.US)$ i don't get it who is selling now??

Trytosaveabit

Mar 26 20:43

news

$Silo Pharma (SILO.US)$ Reuters· 1 min ago
Silo Pharma Achieves Key Milestone With First Dosing in Ind-Enabling Glp Study for Spc-15 as a Groundbreaking Ptsd Treatment

1

2

Teddy123

Mar 26 20:42

Silo Pharma Achieves Key Milestone with First Dosing in IND-Enabling GLP Study for SPC-15 as a Groundbreaking PTSD Treatment

$Silo Pharma (SILO.US)$
Major PTSD Treatment Advance: FDA Fast-Track Path Opens for Revolutionary Drug SPC-15

Jaguar8

Mar 26 20:40

NEWS

$Silo Pharma (SILO.US)$
Silo Pharma Achieves Key Milestone with First Dosing in IND-Enabling GLP Study for SPC-15 as a Groundbreaking PTSD Treatment
Wednesday, 26th March at 8:40 am
Preclinical Data to Support Advancement Toward First-in-Human Clinical Trials
SARASOTA, FL, March 26, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (NASDAQ: SILO) ("Silo" or the "Company"), a developmental stage biopharmaceutical company focused on novel therapeutics and drug delivery systems, today announced first d...

SILO Silo Pharma

Trade Overview

Capital Trend

News

Comments

Market Insights

Latest News

Investment Course

Discussing

Monetary Policy: Navigating the Fed's Rate Cut Cycle